Foltynie · Lancet (London, England) 2024 · narrative review · n=?

Medical, surgical, and physical treatments for Parkinson's disease.

Cited 232 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review and expert opinion paper with no original human data or systematic review methodology reported

PubMed 38245250 · doi:10.1016/S0140-6736(23)01429-0 · record verified 2026-08-30

What was done

This paper summarizes evidence and expert recommendations for medical, surgical, and physical interventions for Parkinson's disease, covering dopamine replacement approaches, management of motor fluctuations, non-motor symptoms, and refractory disease features.

What was found

The abstract reports no numerical results, sample sizes, or effect estimates. It qualitatively outlines the role of dopamine replacement, multidisciplinary strategies for complex motor and non-motor symptoms, and the continuing absence of disease-modifying treatments for refractory symptoms such as gait/balance difficulties, cognitive impairment, and speech or swallowing impairments.

Why it matters

It provides a consolidated multidisciplinary framework and expert consensus to guide clinical choices in Parkinson's disease where formal evidence is limited.

Limits

The abstract describes a narrative review rather than a systematic review or empirical study, reports no quantitative data, and provides expert-level recommendations for areas lacking strong evidence bases.

Cited by